SOPHiA GENETICS to Announce Financial Results for Third Quarter 2026 on November 3, 2026
SOPHiA GENETICS (SOPH) will release its third-quarter 2026 financial results before U.S. markets open on November 3, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
SOPHiA GENETICS (SOPH) will release its third-quarter 2026 financial results before U.S. markets open on November 3, 2026.
A conference call covering the results and business outlook will begin at 8:00 a.m. EDT / 2:00 p.m. CET that day. A live webcast and subsequent replay will be available on the company’s investor relations website.
AI-generated analysis. How Rhea-AI works. Not financial advice.
The call will be webcast live on the SOPHiA GENETICS Investor Relations Website. Additionally, a replay will be available on the website after its completion.
About SOPHiA GENETICS
SOPHiA GENETICS (Nasdaq: SOPH) is an AI-native healthcare technology company on a mission to transform patient care by expanding access to data-driven medicine globally. It is the creator of SOPHiA DDM™, an AI platform that analyzes complex genomic and multimodal data to generate real-time, real-world insights for a broad global network of hospital, laboratory, and biopharma institutions. For more information, visit SOPHiAGENETICS.COM and connect with us on LinkedIn.
View original content to download multimedia:https://www.prnewswire.com/news-releases/sophia-genetics-to-announce-financial-results-for-third-quarter-2026-on-november-3-2026-302910390.html
SOURCE SOPHiA GENETICS